Medical Policy and Coding Updates - April 2023
Summary
Codes J0218, J1747, J9294, J9296, J9297, Q5127, Q5128, Q5129, Q5130 and Carelon genetic testing codes 0364U, 0368U, 0378U, 0379U and 0380U now require medical necessity review and prior authorization effective April 1, 2023. Codes A2019 through A2021, Q4265 through Q4271 and several others now require investigational review, and C9757 for lumbar spine decompression no longer requires medical necessity review but now requires investigational review. The update also added Syfovre for geographic atrophy, Filspari for IgA nephropathy and Orserdu for ESR1-mutated breast cancer.
Get alerts when payers change rules like this one
We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.